EUVIMEDObjevte EUVIMED
Crossref

Determining patient value profiles in psoriasis

N T Hilhorst iD, E Abatih, E Deprez, J L W Lambert, I Hoorens

Experimental Dermatology · 2023

DOI: 10.1111/exd.14906 ↗

At a glance

Journal article in Experimental Dermatology, 2023. Written by N T Hilhorst and 4 co-authors. Institution: Dermatology Research Unit, Ghent University, Ghent, Belgium. Major MEDLINE topics: Psoriasis, Quality of Life. Cited 1 times so far (Crossref); 24 references. Funded by: Novartis.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Healthcare professionals (HCPs) should strive to create the maximum value for their patients in which value is defined as the patient‐relevant health outcomes achieved per costs made. However, currently it remains difficult to determine which outcomes matter to an individual psoriasis patient.

Objective

To define outcome profiles, or so called ‘patient value profiles’, within a cohort of psoriasis patients that can be translated to daily practice to increase value for the individual patient.

Methods

Hierarchical clustering on principal components (HCPC) was used to identify groups of patients sharing the same profile within an outcome ranking exercise. Once the clusters were defined, their characterization was provided based on a V‐test. In a final step, a multi‐class decision tree (MDT) based on relevant socio‐demographic and clinical variables was built to allocate patients to a cluster.

Results

In the ranking exercise 120 patients participated. The median age was 50.0 (IQR 25.0) years and 36.7% were female. Median PASI score was 2.4 (IQR 5.2) and median duration of psoriasis was 17.0 (IQR 20.0) years. Primary treatment varied from topicals to biologicals. We found three distinct patient value profiles in this cohort ( QoL , cost and treatment ). A MDT was built which had an accuracy of 64%.

Conclusion

We found three distinct patient value profiles in a cohort of psoriasis patients and patients can be easily assigned to one of these profiles based on a MDT. HCPs can use these profiles to steer psoriasis management accordingly allowing for a more goal‐orientated approach.

Subjects

MeSH terms (MEDLINE)

PsoriasisQuality of LifeHumansMiddle AgedSeverity of Illness IndexTreatment OutcomeAdultAgedMaleFemaleValue of Life

Author keywords

outcomespsoriasisvalue

Authors and institutions

  • Dermatology Research Unit, Ghent University, Ghent, Belgium.
  • Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Department of Applied Mathematics, Computer Sciences and Statistics, Ghent University, Ghent, Belgium.

ORCID profiles: N T Hilhorst

Funding

  • Novartis

Cite

APA

Hilhorst, N. T., Abatih, E., Deprez, E., Lambert, J. L. W., & Hoorens, I. (2023). Determining patient value profiles in psoriasis. Experimental Dermatology. https://doi.org/10.1111/exd.14906

Vancouver

Hilhorst NT, Abatih E, Deprez E, Lambert JLW, Hoorens I. Determining patient value profiles in psoriasis. Experimental Dermatology. 2023. doi:10.1111/exd.14906

BibTeX
@article{Hilhorst2023,
  author = {Hilhorst, N T and Abatih, E and Deprez, E and Lambert, J L W and Hoorens, I},
  title = {Determining patient value profiles in psoriasis},
  journal = {Experimental Dermatology},
  year = {2023},
  doi = {10.1111/exd.14906}
}
Start for free →